AirSculpt Technologies (AIRS) investor relations material

Market positioning and business model

• Operates 31 centers with over 350 employees, performing more than 12,000 procedures annually and maintaining a ~60% gross margin.

• Utilizes a proprietary, minimally invasive body sculpting method with immediate, permanent results and high patient satisfaction.

• Achieves consistent revenue per case ($12,000–$13,000) and rapid profitability for new centers, with mature centers requiring minimal additional investment.

Growth strategy and revenue outlook

• 2026 revenue guidance is $151M–$157M, with adjusted EBITDA of $15M–$17M, reflecting ~2.4% comparable revenue growth and ~28% EBITDA growth.

• Three main growth levers: enhanced marketing, expanded services (including GLP-1 patient focus), and de novo center expansion.

• Significant white space for expansion, with potential for 200–300 additional U.S./Canada centers and 150–250 international centers.

Operational improvements and financial discipline

• Strengthened balance sheet by reducing debt by ~$30M, achieving net debt to EBITDA below 2.5x and increasing liquidity.

• Streamlined operations and refreshed executive team, generating over $4M in annualized savings and improving organizational efficiency.

• Maintains strong financial discipline in margins and capital allocation, with a focus on productivity and cost management.